Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits

Annals of the Academy of Medicine Singapore

Volumn 36, Issue 8, 2007, Pages 636-641

  Dashraath, P ^a   Ong, Eng Seng ^b   Lee, Vernon J ^c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Headquarters SAF Medical Corps

^c Singapore Army   (Singapore)

^d NONE   (Singapore)

Author keywords

Antibody; Chickenpox; Cost effective; Military; Seroprevalence; Varicella zoster

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ARTICLE; CHICKENPOX; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; SEROEPIDEMIOLOGY; SEROPREVALENCE; SINGAPORE; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 34548492771     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, et al. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr 2000;37:714-9.
2. Lee JJ, Shek PC, Ma S, Chew SK, Chew FT, Lee BW. Economic burden of varicella in Singapore - a cost benefit estimate of implementation of a routine varicella vaccination. Southeast Asian J Trop Med Public Health 2004;35:693-6.
3. Ministry of Health, Singapore. Communicable Disease Surveillance in Singapore 2004. Singapore: Ministry of Health, Singapore, 2005.
4. De Juanes JR, Gil A, San-Martin M, Gonzalez A, Esteban J, Garcia de Codes A. Seroprevalence of varicella antibodies in healthcare workers and health sciences students. Reliability of self-reported history of varicella. Vaccine 2005;23:1434-6.
5. Saha SK, Darmstadt GL, Hanif M, Khan R. Seroepidemiology of varicella-zoster virus in Bangladesh. Ann Trop Paediatr 2002;22:341-5.
6. Kudesia G, Partridge S, Farrington CP, Soltanpoor N. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy. J Clin Pathol 2002;55:154-5.
7. Vandersmissen G, Moens G, Vranckx R, de Schryver A, Jacques P. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study. Occup Environ Med 2000;57:621-6.
8. Ooi PL, Goh KT, Doraisingham S, Ling AE. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J Trop Med Public Health 1992;23:22-5.
9. Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001;20:121-4.
10. Chong CY, Lim SH, Ng WY, Tee N, Lin RV. Varicella screening and vaccination for healthcare workers at KK Women's and Children's Hospital. Ann Acad Med Singapore 2004;33:243-7.
11. MacMahon E, Brown LJ, Bexley S, Snashall DC, Patel D. Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study. BMJ 2004;329:551-2.
12. Singapore Residents by Age Group, Ethnic Group and Sex. Statistics Singapore. Available at: http://www.singstat.gov.sg/keystats/c2000/indicators. pdf. Accessed 15 May 2006.
13. Banz K, Wagenpfeil S, Neiss A, Goertz A, Staginnus U, Vollmar J, et al. The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine 2003;21:1256-67.
14. Wallace MR, Chamberlin CJ, Zerboni L, Sawyer MH, Oldfield EC, Olson PE, et al. Reliability of a history of previous varicella infection in adults. JAMA 1997;278:1520-2.
15. Jerant AF, DeGaetano JS, Epperly TD, Hannapel AC, Miller DR, Lloyd AJ. Varicella susceptibility and vaccination strategies in young adults. J Am Board Fam Pract 1998;11:296-306.
16. Burnham BR, Wells TS, Riddle JR. A cost-benefit analysis of a routine varicella vaccination program for United States Air Force Academy cadets. Mil Med 1998;163:631-4.
17. Alagappan K, Fu L, Strater S, Atreidis V, Auerbach C. Seroprevalence of varicella antibodies among new house officers. Ann Emerg Med 1999;33:516-9.
18. Coyle PV, McCaughey C, Wyatt DE, O'Neill HJ. Varicella vaccine in pregnancy. Testing should be offered to women without a history of chickenpox. BMJ 1997;314:226.
19. Holmes SJ. Review of recommendations of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, on varicella vaccine. J Infect Dis 1996;174:S342-S344.
20. Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med 1999;130:922-32.
21. Gallagher J, Quaid B, Cryan B. Susceptibility to varicella zoster virus infection in health care workers. Occup Med (Lond) 1996;46:289-92.